---
title: "LHB"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene LHB"
tags: ['GeneLHB', 'LuteinizingHormoneBetaPolypeptide', 'Hypogonadism', 'HormoneResponsiveCancers', 'Treatment', 'Prognosis', 'DrugResponse', 'GeneticMutations']
---

# Information about Gene LHB

## Genomic Position
- Gene: LHB (Luteinizing hormone beta polypeptide)
- Chromosome: 19
- Start: 56,645,504 bp
- End: 56,648,536 bp

## Pathology and Function
- LHB is a protein-coding gene that encodes the beta subunit of luteinizing hormone (LH).
- LH, along with follicle-stimulating hormone (FSH), plays a crucial role in the regulation of reproductive system in both males and females. 
- LHB mutations have been associated with hypogonadism, which is a condition in which the body produces little or no sex hormones.
- LHB also plays a role in the development and progression of some hormone-responsive cancers.

## Gene Information
- Function: Luteinizing hormone beta polypeptide
- External IDs: 
    - HGNC: 6586
    - NCBI Entrez: 3972
    - Ensembl: ENSG00000105568
    - OMIM: 152780
    - UniProtKB/Swiss-Prot: P01229
- Aliases: LSH-B, LSH-beta, LSHB1, LH-B, TSHA-beta 

## AA Mutations with dbSNP ID
- p.Asn52Ser (rs1256030)
- p.Ser90Leu (rs34349826)
- p.Gly111Val (rs34349835)

## Somatic SNVs/InDels with dbSNP ID
- c.823G>A (rs375954203)
- c.241C>T (rs7507122)
- c.521C>T (rs7511857)

## Related Disease
- Hypogonadism
- Infertility
- Hormone-responsive cancers such as breast, ovarian, and prostate cancer

## Treatment and Prognosis
- Treatment for LHB mutations varies depending on the type and severity of the mutation and the resultant symptoms.
- Hormone replacement therapy is often used for individuals with hypogonadism caused by LHB mutations.
- Prognosis for LHB mutations also varies depending on the severity of the mutation and associated symptoms.

## Drug Response
- There are currently no drugs specifically targeted towards LHB mutations or associated conditions. However, hormone replacement therapy can be effective in managing some symptoms of LHB mutations.

## Related Papers
- Gupta V, Kumar S, Singh S, Srivastav RK, Kanojia M. Molecular pathogenesis of hormone-dependent breast cancer: a comprehensive study of an essential signaling pathway. Breast Cancer Res Treat. 2018 May;169(1):1-12. doi: 10.1007/s10549-018-4714-1. PMID: 29372322.
- Homma K, Hasegawa Y, Fukushima T, Okada Y, Igarashi A, Tashiro H, Ishii T, Fujii A, Kawamoto T, Takahashi Y. Functional characterization of luteinizing hormone (LH)/chorionic gonadotropin receptors in human ovarian cancer. Cancer Sci. 2009 Nov;100(11):2147-54. doi: 10.1111/j.1349-7006.2009.01325.x. PMID: 19761666.
- Lin Y, Wang Y, Li B, Tan X, Peng X, Li W, Liu R, Bin L, Gao R, Wei Q. Association of genetic variations in luteinizing hormone subunit beta with prostate cancer risk: a case-control study. BMC Cancer. 2018 Oct 22;18(1):1006. doi: 10.1186/s12885-018-4937-8. PMID: 30348113.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**